Ritesh P Daya Selected Research

3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamide

1/2018	The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia.
3/2013	PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ritesh P Daya Research Topics

Disease

3	Schizophrenia (Dementia Praecox) 01/2018 - 05/2012
2	Mental Disorders (Mental Disorder) 03/2013 - 09/2011
1	Movement Disorders (Movement Disorder) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Tardive Dyskinesia 09/2011

Drug/Important Bio-Agent (IBA)

2	Haloperidol (Haldol)FDA LinkGeneric 01/2018 - 09/2011
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018 - 03/2013
2	3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamideIBA 01/2018 - 03/2013
2	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 09/2011
1	MSH Release-Inhibiting Hormone (MIF-I)IBA 01/2018
1	N-Methylaspartate (NMDA)IBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Phencyclidine (Angel Dust)IBA 01/2018
1	Dizocilpine Maleate (Dizocilpine)IBA 03/2013
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 03/2013
1	PhosphoproteinsIBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Messenger RNA (mRNA)IBA 05/2012
1	Synapsins (Synapsin I)IBA 05/2012
1	phenyl-N-tert-butylnitroneIBA 09/2011

Therapy/Procedure

1	Therapeutics 03/2013